Renescience A/S: Financial statements 2013
CVR: 31846803
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Renescience A/S (CVR 31846803) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -25,570,000 and a net result of DKK -19,925,000 compared with DKK -16,641,000 the year before. Equity in the 2013 report amounted to DKK 27,680,000. The solvency ratio was 89.6%.
- Gross Profit
- DKK -25,570,000
- Profit/Loss
- DKK -19,925,000
- Equity
- DKK 27,680,000
- Total Assets
- DKK 30,887,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -25.6 mio. | -19.9 mio. | 27.7 mio. | - |
| 2012 | - | -21 mio. | -16.6 mio. | 17.6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Renescience A/S has published its annual report for 2012. Gross profit came to DKK -20,994,000, and the net result was DKK -16,641,000.
As of April 24, 2013, Ørsted New Bio Solutions Holding A/S is registered as an owner of Renescience A/S with an ownership share of 100%.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.